In
the WHO’s Global Action Plan on Antimicrobial Resistance (AMR), backed by the
UN, the prevention of infection is one of five strategies to tackle the global
rise of AMR.
Pathogenic
bacteria can survive on standard environmental surfaces in healthcare
facilities, leading to the risk of patients acquiring an infection. Bacteria
deposited and surviving on a surface can exchange genes, including those for
antibiotic resistance, which can result in new, resistant strains.
Hand
hygiene, and surface cleaning and disinfection are standard measures to prevent
and control HCAIs, but more needs to be done to prevent the spread of pathogens
by staff, visitors and patients touching contaminated surfaces.
Professor
Bill Keevil, Chair in Environmental Healthcare at the University of
Southampton, is a leading expert on the hygienic properties of copper, and believes
replacing frequently-touched surfaces with antimicrobial copper equivalents,
teamed with good hygiene practices, could help address both the environmental
spread of contamination and the rise of antibiotic resistance.
Copper
is a powerful antimicrobial with rapid, broad-spectrum efficacy against
bacteria and viruses, and has been shown to kill disease-causing pathogens,
including influenza A, E.coli and norovirus, and resistant bacteria including
Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant
Enterobacteriaceae (CRE) and Vancomycin-resistant Enterococcus (VRE). It shares
this benefit with a range of copper alloys, such as brasses and bronzes,
forming a family of materials collectively called ‘antimicrobial copper’.
‘We’ve
shown that antimicrobial copper touch surfaces produce a rapid kill of
bacteria, viruses and fungi, usually within minutes,’ says Professor Keevil.
‘EPIC 3 - the national, evidence-based guidelines for preventing HCAIs in NHS
Hospitals in England - recognise high-touch surfaces made from antimicrobial
copper harbour 80-90% fewer bacteria than equivalent, non-copper surfaces. A
multicentre trial in the US further showed a concurrent 58% reduction in HCAIs
in ICU rooms equipped with antimicrobial copper touch surfaces.’
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources